Tonghua Dongbao Pharmaceutical Co Ltd (600867) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥62.99 Million ≈ $9.22 Million USD) by net assets (CN¥7.14 Billion ≈ $1.04 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Tonghua Dongbao Pharmaceutical Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.
Tonghua Dongbao Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Tonghua Dongbao Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Tonghua Dongbao Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tonghua Dongbao Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore earnings quality score of Tonghua Dongbao Pharmaceutical Co Ltd to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Axogen Inc
NASDAQ:AXGN
|
0.006x |
|
Central Puerto S.A.
BA:CEPU
|
0.035x |
|
Navios Maritime Partners LP Unit
NYSE:NMM
|
0.037x |
|
Livzon Pharmaceutical Group Inc
SHE:000513
|
0.040x |
|
Northwest Bancshares Inc
NASDAQ:NWBI
|
0.017x |
|
Energa S.A.
WAR:ENG
|
0.085x |
|
Indraprastha Gas Limited
NSE:IGL
|
0.009x |
|
Shenzhen SDG Information Co Ltd
SHE:000070
|
-0.029x |
Annual Cash Flow Conversion Efficiency for Tonghua Dongbao Pharmaceutical Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Tonghua Dongbao Pharmaceutical Co Ltd from 1998 to 2025. View Tonghua Dongbao Pharmaceutical Co Ltd (600867) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥7.11 Billion ≈ $1.04 Billion |
CN¥689.23 Million ≈ $100.86 Million |
0.097x | +35.00% |
| 2024-12-31 | CN¥6.40 Billion ≈ $936.58 Million |
CN¥459.74 Million ≈ $67.27 Million |
0.072x | -39.83% |
| 2023-12-31 | CN¥7.22 Billion ≈ $1.06 Billion |
CN¥861.52 Million ≈ $126.07 Million |
0.119x | -9.40% |
| 2022-12-31 | CN¥6.55 Billion ≈ $958.41 Million |
CN¥863.09 Million ≈ $126.30 Million |
0.132x | -27.75% |
| 2021-12-31 | CN¥6.22 Billion ≈ $910.21 Million |
CN¥1.13 Billion ≈ $166.02 Million |
0.182x | -14.95% |
| 2020-12-31 | CN¥5.56 Billion ≈ $813.52 Million |
CN¥1.19 Billion ≈ $174.47 Million |
0.214x | -6.77% |
| 2019-12-31 | CN¥5.01 Billion ≈ $732.95 Million |
CN¥1.15 Billion ≈ $168.60 Million |
0.230x | +24.18% |
| 2018-12-31 | CN¥4.73 Billion ≈ $692.77 Million |
CN¥876.94 Million ≈ $128.32 Million |
0.185x | -12.56% |
| 2017-12-31 | CN¥4.54 Billion ≈ $663.97 Million |
CN¥961.19 Million ≈ $140.65 Million |
0.212x | +15.15% |
| 2016-12-31 | CN¥3.95 Billion ≈ $577.31 Million |
CN¥725.76 Million ≈ $106.20 Million |
0.184x | +54.81% |
| 2015-12-31 | CN¥2.48 Billion ≈ $362.76 Million |
CN¥294.58 Million ≈ $43.11 Million |
0.119x | +24.69% |
| 2014-12-31 | CN¥2.16 Billion ≈ $316.15 Million |
CN¥205.89 Million ≈ $30.13 Million |
0.095x | -13.08% |
| 2013-12-31 | CN¥2.02 Billion ≈ $295.04 Million |
CN¥221.06 Million ≈ $32.35 Million |
0.110x | +12.35% |
| 2012-12-31 | CN¥1.99 Billion ≈ $291.37 Million |
CN¥194.32 Million ≈ $28.44 Million |
0.098x | +468.21% |
| 2011-12-31 | CN¥2.08 Billion ≈ $304.07 Million |
CN¥-55.07 Million ≈ $-8.06 Million |
-0.027x | -128.63% |
| 2010-12-31 | CN¥1.73 Billion ≈ $253.53 Million |
CN¥160.40 Million ≈ $23.47 Million |
0.093x | -9.39% |
| 2009-12-31 | CN¥1.63 Billion ≈ $238.04 Million |
CN¥166.20 Million ≈ $24.32 Million |
0.102x | +58.67% |
| 2008-12-31 | CN¥1.43 Billion ≈ $209.78 Million |
CN¥92.31 Million ≈ $13.51 Million |
0.064x | -18.33% |
| 2007-12-31 | CN¥1.53 Billion ≈ $224.47 Million |
CN¥120.94 Million ≈ $17.70 Million |
0.079x | -36.33% |
| 2006-12-31 | CN¥1.28 Billion ≈ $186.72 Million |
CN¥158.00 Million ≈ $23.12 Million |
0.124x | +80.01% |
| 2005-12-31 | CN¥1.34 Billion ≈ $196.19 Million |
CN¥92.23 Million ≈ $13.50 Million |
0.069x | +592.91% |
| 2004-12-31 | CN¥1.33 Billion ≈ $194.05 Million |
CN¥13.17 Million ≈ $1.93 Million |
0.010x | -69.43% |
| 2003-12-31 | CN¥1.40 Billion ≈ $205.04 Million |
CN¥45.51 Million ≈ $6.66 Million |
0.032x | +38.36% |
| 2002-12-31 | CN¥1.36 Billion ≈ $199.45 Million |
CN¥31.99 Million ≈ $4.68 Million |
0.023x | -72.51% |
| 2001-12-31 | CN¥1.38 Billion ≈ $201.72 Million |
CN¥117.73 Million ≈ $17.23 Million |
0.085x | +317.87% |
| 2000-12-31 | CN¥1.43 Billion ≈ $208.52 Million |
CN¥29.12 Million ≈ $4.26 Million |
0.020x | +130.19% |
| 1999-12-31 | CN¥1.40 Billion ≈ $205.54 Million |
CN¥-95.09 Million ≈ $-13.91 Million |
-0.068x | +71.02% |
| 1998-12-31 | CN¥928.90 Million ≈ $135.93 Million |
CN¥-216.98 Million ≈ $-31.75 Million |
-0.234x | -- |
About Tonghua Dongbao Pharmaceutical Co Ltd
Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug tr… Read more